




Influence of Chromium-Cobalt-Molybdenum Alloy
(ASTM F75) on Bone Ingrowth in an Experimental
Animal Model
Jésica Zuchuat 1,*, Marcelo Berli 2, Ysaí Maldonado 3 and Oscar Decco 1
1 Bioimplants Laboratory, Faculty of Engineering, National University of Entre Rios, Oro Verde,
Entre Rios E3100, Argentina; odecco@bioingenieria.edu.ar
2 Computational Biomechanics Group, Faculty of Engineering, National University of Entre Rios,
Oro Verde, Entre Rios E3100, Argentina; mberli@bioingenieria.edu.ar
3 Imaging Service, Sanatorio Adventista Del Plata, 25 De Mayo 255, Villa Libertador General San Martín,
Entre Ríos E3103, Argentina; ysai.maldonado@sanatorioadventista.com.ar
* Correspondence: jzuchuat@bioingenieria.edu.ar; Tel.: +54-343-497-5100 (ext. 110)
Received: 20 October 2017; Accepted: 20 December 2017; Published: 26 December 2017
Abstract: Cr-Co-Mo (ASTM F75) alloy has been used in the medical environment, but its use as
a rigid barrier membrane for supporting bone augmentation therapies has not been extensively
investigated. In the present study, Cr-Co-Mo membranes of different heights were placed in New
Zealand white, male rabbit tibiae to assess the quality and volume of new bone formation, without
the use of additional factors. Animals were euthanized at 20, 30, 40, and 60 days. Bone formation
was observed in all of the cases, although the tibiae implanted with the standard membranes
reached an augmentation of bone volume that agreed with the density values over the timecourse.
In all cases, plasmatic exudate was found under the membrane and in contact with the new
bone. Histological analysis indicated the presence of a large number of chondroblasts adjacent
to the inner membrane surface in the first stages, and osteoblasts and osteocytes were observed
under them. The bone formation was appositional. The Cr-Co-Mo alloy provides a scaffold with
an adequate microenvironment for vertical bone volume augmentation, and the physical dimensions
and disposition of the membrane itself influence the new bone formation.
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1. Introduction
Bone resorption occurs in a wide variety of clinical situations, such as trauma, injury, bone illness,
or hormonal disorders. This decrease, either in bone volume or in bone quality, can produce aesthetic
and functional complications, depending on the defect location and the function of the involved bone,
that directly affect the patient’s activities and increases morbidity.
During the last few years, remarkable progress in the development of new orthopaedic techniques
(i.e., distraction osteogenesis, bone augmentation through the application of rhBMP-2 and genetic
therapies) and a great number of surgical procedures has been created to support and improve bone
reconstruction outcomes [1]. Although those techniques have significantly transformed reconstructive
surgery and improved clinical results, currently they have some limitations, such as the shortage of
required materials, since autologous bone grafts are employed as the standard against which the rest
of the methods are compared [2,3]. Autologous bone combines all of the properties of a graft material,
providing a scaffold for the inner growth of osteoprogenitor cells (osteoconductivity) and stimulating
stem cell proliferation and differentiation in osteogenic cell lines (osteoinductivity) to help maintain
the viable cells that form new bone tissue (osteogenicity) [3,4]. However, the amount of autologous
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bone available from a patient is limited and requires an additional surgical procedure to harvest it,
which increases the morbidity of the donor site and may cause chronic pain or dysesthesia in the
harvest site [5].
Recent advances in bone tissue engineering have given surgeons new treatment options in order
to restore the form and function of the involved tissue [4]. Research and development of different
technologies include three-dimensional (3D) printing, sputtering coatings, and electro-spinning
techniques for the development of resorbable and non-resorbable materials. These materials are
combined with growth factors, bone morphogenetic proteins (BMPs), or other elements or substances,
which act as carriers. Certain substances regulate the actions of osteoprogenitor cells at the target site
and control the degradation and physical resorption rates in the host environment, so the materials
are replaced by the regenerated bone. These new techniques and new computational models that are
capable of predicting bone evolution and bone remodelling are intended to overcome the problems
found in the previous models. They are seen as promising approaches for the prediction of bone
growth and for faster and easier methods of tissue regeneration and repair.
Masquelet et al. (1996) [6] described for the first time a technique of two stages with the aim
to take advantage of the immune response against the implantation of foreign materials for the
reconstruction of critical bone defects. The Masquelet technique is based on the temporary placement
of polymethylmethacrylate (PMMA) membranes. They are fixed to cover the site of the defect and
create a biologically active tissue, called an “inducted membrane”, which is highly vascularized and
rich in growth factors, such as vascular endothelial growth factor (VEGF) and transforming growth
factor beta (TGF-β1) [7–9]. After approximately four or eight weeks, a bone substitute, generally
an autologous bone graft that includes all of the possible limitations mentioned above, is placed.
Since the first study, the Masquelet technique has been widely used and modified with the development
of new technologies to solve massive bone defects, while maintaining its clinical efficacy [10–12].
In a similar way, in the last few decades, the rigid, osteoconductive, and non-resorbable barrier
membranes are used as part of regenerative treatments, and bone augmentation therapies have been
thoroughly researched [13] as additional methods to improve osteoinduction and cell differentiation
mechanisms [14–19]. Membranes contribute to the creation of a favourable microenvironment in the
lesion site. There is evidence that those membranes could prevent the migration of non-desirable cells
and allow for the migration of osteoprogenitor cells, guaranteeing the formation of new bone tissue
and avoiding fibrous tissue proliferation.
The Cr-Co-Mo alloy (ASTM F75) was one of the first Cobalt-based alloys that was used as
a biomaterial and gained popularity for its use as orthopaedic implant material, especially in total
joint replacements and in odontology [20]. It is currently used because of its biocompatibility and
good mechanical properties [21,22]. Previous studies done by this research group have concluded
that membranes that are generated by the cast manufacturing method of Cr-Co-Mo alloy have as
good performance for bone formation when used in combination with synthetic bone substitutes as
autogenous substances do when they were tested in an animal model [14,15]. Additionally, it has been
observed that the implantation of the Cr-Co-Mo alloy itself in control animals has the same results as
those in the previous case, although in a longer time. It is believed that the alloy has promoted and
induced osteoblast migration to the site of the implantation, influencing their proliferation following
bone augmentation and assuming a centripetal pattern of growth.
The aim of the present study was to assess the induction of the Cr-Co-Mo alloy on the bone
formation rate though the implantation of membranes of two heights in rabbit tibia. We assessed
the pattern of growth of new bone in a longitudinal study to determine if the differentiation of the
mesenchymal stem cells into osteoblast cells is induced by the membrane itself or another origin,
or both. The results were assessed and compared microscopically, densitometrically, radiologically,
and in computed tomography (CT) images.
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2. Results
2.1. Macroscopic Analysis
After the sacrifice of each of the experimental animals, bone augmentation was observed (Figure 1)
in all of them. We even in some cases observed bone augmentation over the Co-Cr membrane, in its
surroundings, and at the micro-screw.
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Figure 1. Macroscopic images of the augmented bone volume at: 20 days for SM (a) and HM (b); 30 
days for SM (c) and HM (d); 40 days for SM (e) and HM (f); 60 days for SM (g) and HM (h). SM: Tibia 
implanted with standard membrane and HM: Tibia implanted with high membrane. 
2.2. Tomographic Analysis 
Due to the longitudinal character of the present study, the changes in bone volume was non-
uniform in most of the cases, which made its quantification difficult. The CT images were used to 
obtain the 3D reconstruction and to assess the volume obtained in each stage of the study (Figure 2). 
The augmented volumes are shown in Table 1. 
 
Figure 2. (a) Three-dimensional (3D) reconstruction of the rabbit tibia with the augmented bone 
volume. (b) Transversal cuts (1 mm) from which the augmented volumes were quantified (marked in 
the images by yellow circles). 
Table 1. Augmentation volumes obtained. 
Days 
Standard Membrane High Membrane 
Augmentation Volume [mm3] Augmentation Volume [mm3] 
20 15.63 18.23 
30 20.61 20.66 
40 22.79 17.58 
60 27.16 11.41 
2.3. Histological Analysis 
The bone biopsies from the day of surgery were analysed to describe the remodelling activity in 
the zones surrounding the location of the membrane. The analysis was performed by the protocol 
described in Section 2.3. The number of cells was quantified at 40×. A mean number of 117.5 
Figure 1. Macroscopic images of the augmented bone volume at: 20 days for SM (a) and HM (b);
30 days for SM (c) and HM (d); 40 days for SM (e) and HM (f); 60 days for SM (g) and HM (h).
SM: Tibia implanted with standard membrane and HM: Tibia implanted with high membrane.
2.2. Tomographic Analysis
Due to the longitudinal character of the present study, the changes in bone volume was
non-uniform in most of the cases, which made its quantification difficult. The CT images were
used to obtain the 3D reconstruction and to assess the volume obtained in each stage of the study
(Figure 2). The augmented volumes are shown in Table 1.
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2.3. Histological Analysis
The bone biopsies from the day of surgery were analysed to describe the remodelling activity in
the zones surrounding the location of the membrane. The analysis was performed by the protocol
described in Section 2.3. The number of cells was quantified at 40×. A mean number of 117.5 osteocytes
in the tibiae implanted with the standard membranes and a mean of 120.0 osteocytes in the tibiae
implanted with the high membranes were found. No osteoblasts or osteoclasts were noted in any of
the cases. There were no apparent differences in osteocyte populations between tibiae or animals.
For the histological analysis, the bone samples were cut in longitudinal sections on the largest
radius of the augment. The samples were prepared to analyse histological components with the aim to
elucidate the mechanism of bone formation (Figure 3).
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The cell quantification of samples from the augmented region is shown in Table 2.
Table 2. Cell counting from the newly formed tissue.
Days
Average Osteoblasts Average Osteocytes
Standard Membrane High Membrane Standard Membrane High Membrane
20 960 (10 fgm) 310 (10 fgm) 580 (10 fgm) 940 (10 fgm)
30 50 (4 fgm) 1400 (10 fgm) 270 (4 fgm) 1100 (10 fgm)
40 1000 (10 fgm) 300 (10 fgm) 680 (10 fgm) 400 (10 fgm)
60 33 (10 fgm) 310 (10 fgm) 360 (10 fgm) 800 (10 fgm)
fgm: Fields of greatest magnification.
Chondroblasts were not quantified, but a large number of them were observed, especially in the
augments of animals sacrificed at that were 20 and 30 days of study, constituting an osteocartilaginous
tissue. Laminar and osteoid bone was found in all of the augmented bones of the animals that were
sacrificed at 40 and 60 days postoperatively.
2.4. Densitometric Analysis
The density differences between samples with standard and high membranes were analysed
over the timecourse and are shown in Table 3. Values are also presented as ratio between the ROIint
(Region of Interest of the bone formation) and ROIref (Region of Interest of reference) throughout
the study.
Table 3. Bone density values.
Days
Standard Membrane High Membrane
ROIint (SD) ROIref (SD) Ratio (%) ROIint (SD) ROIref (SD) Ratio
20 77.90 (0.85) 190.61 (8.64) 40.91 (1.61) 65.86 (2.29) 148.48 (4.91) 44.42 (3.01)
30 59.66 (5.69) 127.51 (20.99) 47.16 (3.92) 64.92 (5.13) 162.51 (3.33) 39.99 (3.76)
40 78.68 (8.18) 165.38 (3.09) 47.62 (5.57) 117.65 (13.74) 185.86 (3.82) 63.24 (6.64)
60 86.04 (1.80) 163.12 (13.55) 52.93 (3.28) 106.39 (4.29) 185.77 (1.17) 57.28 (2.58)
Control 153.46 (0.97) 162.94 (1.59) 94.19 (1.51) 153.97 (0.57) 163.88 (2.05) 93.96 (1.45)
In Figure 4a, it can be observed that the mean ratio of density values for the tibiae implanted with
the standard membrane increased progressively during the experimental period. In Figure 4b, the box
plot shows the values of the tibiae implanted with the high membrane.
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3. Discussion
Most of the studies concerning vertical bone augmentation from non-critical bone defects involve
the use of different techniques and materials, which are generally combined with natural, autologous
substrates. Grafts, growth factors, mesenchymal stem cells, and bone morphogenetic proteins,
among others [14,15,23,24], are used to obtain successful results in animals [25] and humans [26].
In complex clinical situations, it is unclear if it is possible to augment the bone beyond the bone surface,
and this remains an aspect to be investigated. Some studies have shown that it is possible [27,28].
Those defects in which the membrane is not supported adequately by local bone walls, as in the sites for
localized vertical augmentation of the bone crest are more difficult to reach. To overcome this obstacle,
resorbable membranes have been used. The material degradation rate can significantly alter bone
formation [29,30]. When the membranes are exposed to inflammatory reactions of the adjacent tissue,
the enzymatic activity of macrophages and neutrophils causes early membrane degradation, affecting
its structural integrity and resulting in a decrease in the barrier function. Other studies [14,15,29] have
centred on the use of rigid, non-resorbable membranes and fixation and support devices, such as
microscrews and microplates. The creation and maintenance of a space between the membrane and
the bone surface is essential to reach a successful bone augmentation procedure, and those studies
demonstrate that it is possible for bone to form in an intramembranous way beyond the bone surface.
In the present work, rigid Cr-Co-Mo membranes were used to generate a space. No additional
variables were used, working only on the subjacent bone surface. In all of the cases, the presence of
an exudate over the inner surfaces of the membranes and over the newly formed bone was observed.
Membranes were implanted under the surgical incision site, and they were microfixed to the bone
surface, producing an initial accumulation of neutrophils at the site, followed by a macrophage
infiltration, in which the phagocytes damaged the tissue, triggering the release of growth factors,
such as PDGF, TGF-α, and TGF-β1. The plasmatic exudate that is produced by the initial cicatrisation
process is fundamentally composed of growth factors and proteins, which have a stimulatory effect on
the cellular activity during the new bone formation period. In addition, insulin-like growth factors are
produced. They have a known stimulator influence on the osteoblastic activity [31]. These findings
coincide with those reported by Krishnan, V. and Davidovitch, Z. (2015) [32], who stated that the
vasodilation of the area above a lesion is conducive to the generation of a plasma exudate and
the migration of leukocytes out of blood vessels. Leukocytes occupy the extravascular space in
compromised tissues and release cytokines, and growth factors to stimulate bone remodelling. On bone
formation other hand, Cassell O.C.S et al. (2006) [33] have developed a model, which allowed for the
generation of new tissue in the absence of an added matrix, and under these circumstances, a fibrin-rich
plasma exudate fills the chamber in the first 24 h and acts as the scaffold.
The use of non-resorbable membranes guarantees a sufficient rigidity in order to avoid wall
collapse and to allow for the growth of new bone in the inner space [30]. The surface characteristics of
the membranes that are used in this study give it properties that favour the bone formation process.
The sandblasting with aluminium particles leads to a roughness of 180 µm, within the optimal range
established by Yang, S.L.S. (2015) [34], who expressed that uniform patterns (100 and 500 µm between
consecutive indentations) of peaks and valleys provide a larger surface area and are more conductive
surfaces for the anchorage and securing the tissues. This allowed a progressive augmentation of the
newly formed bone volumes with time in the tibiae implanted with the standard membrane. However,
for the high membrane, an initial augmentation (until 30 days after surgery) was observed, and then
the augmentation decreased progressively towards the end of the study (Table 1). The reason that the
higher membranes led to a slower bone formation can be explained by the potential that is generated
between the surface charges of both the cortical bone (which has an electronegativity in the range of
−5 to +5 mV [35]) and those created by the sandblasting that formed a native oxide layer over the
membrane surfaces. On the other hand, the standard membranes have a higher charge concentration
per unit volume, which has a stimulating effect in osteoprogenitor cells and is in agreement with that
expressed by Chiarenza, A.R. and Weiss, C.M. (1979) [36].
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The biopsies done before the beginning of the study were collected to know the state of the
bone remodelling at the sites close to the membrane implantation. Only osteocytes were observed
in all of the cases that were studied. Over the external membrane surface and in the contact edges,
the osteoblastic activity with new bone formation was observed in all of the cases. On the other
hand, the results of the histologic analysis of the number of osteoblasts does not show a pattern
throughout the study. Although at 20 days after surgery a higher number of osteoblasts was observed
in comparison with the osteocytes in the tibia with the standard membrane, in the tibia with the high
membrane the opposite was observed. Moreover, during the first days, there was a large number of
chondroblasts, especially in the bone augments formed at 20 and 30 days after surgery, congruent
with the longitudinal study design, which allowed us to justify the presence of cartilaginous tissue
in the early stages of the development of new bone. Chondroblasts were located towards the top
of the augmentation, showing the direction of the bone tissue formation and apposition. Under the
chondroblasts, the osteoblasts were observed, indicating the direction of bone formation. Additionally,
osteocytes were observed in the extracellular matrix (ECM) forming a reticular tissue, which coincides
with results the expressed by Park, J. and Lakes, R. S. (2007) [37], who established that an increase
in the amount of collagen marks the beginning of the formation process and occurs approximately
after one week. At four weeks from the beginning, the bone callus is formed by three parts [38].
As can be observed in Figure 3c,d, the disposition of the trabeculae in the woven bone determines
the appositional growth, agreeing with the density values over the timecourse for the tibiae with the
standard membrane.
As described by Degidi, M. et al. [38], for titanium, the physical dimensions and disposition of the
membrane over the subjacent bone influence the new bone formation. The Cr-Co-Mo alloy (ASTM F75)
provides a scaffolding with an adequate microenvironment for vertical bone volume augmentation
and prevents fibrous tissue invasion. Additionally, these non-resorbable membranes provide excellent
mechanical and biocompatible properties to meet the needs of potential applications in guided bone
regeneration. The longitudinal study achieved positive results that allow us to understand the early
stages of bone formation, although additional studies with a large number of samples would be needed
in order to statistically validate the results.
4. Materials and Methods
4.1. Cr-Co-Mo Membranes Manufacture
The membrane design was created using SolidWorks 2013 CAD software (Dassault Systems
SolidWorks Corp, Concord, MA, USA) to grant uniformity to compare the achieved results. Prototypes
were obtained (standard and augmented, Figure 5a) through 3D printing techniques with white opaque
photopolymer (Vero White Plus®) with a 16-micrometre resolution. Prototypes were used as a mould
to manufacture the membrane cast with the Cr-Co-Mo alloy (VITAL®), of Cr 28%, Mo 6%, and Co. 62%
(Figure 5b). Both of the groups of membranes were sandblasted (Figure 6) with 180-µm aluminium
oxide particles (Al2O3) with the same protocol. Membranes were cleaned in an ultrasonic bath of
deionized water for 10 min before sterilisation.
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4.2. Surgical Procedure
Approval from the Superior Council of the National University of Entre Rios was obtained prior
to the start of the study, under the code 6160 through Res CS 237-15. Five adult New Zealand rabbits
weighing between 2.8 kg and 3.4 kg were used as experimental animals. The animals were housed
individually at 21.55 ◦C, with an average relative humidity of 68.37%. They were fed a standard
commercial rabbit chow. Water and food were available ad libitum. The health status of the animals
was regularly checked during the study.
Four experimental rabbits were divided in two groups: Group 1 (n = 4 right tibia of each animal)
were implanted with standard membranes. Group 2 (n = 4 left tibia of each animal) were implanted
with high membranes that provided a larger inner space for bone formation. Membranes were
microfixed in order to avoid displacement or detachment. The remaining rabbit was the control.
Ketamine 50 (Holliday-Scott S.A®, Buenos Aires, Argentina) was administered intramuscularly
for general anaesthesia, 1.5 mL of xylazine 100 (Richmond, Vet Pharma®, Buenos Aires, Argentina)
was used as a muscle relaxant and 1.5 mL of Carticain L-adrenalin (Totalcaina Forte®, Laboratorios
Bernabó, Argentina) was used as local anaesthesia. Radiographs of both tibiae were obtained on day 0
(before surgery). The surgical sites were shaved and disinfected with a povidone-iodine solution
before the operation. A full thickness skin incision was made at the level of the proximal metaphysis
to expose the tibia. The periosteum was removed from the bone surface, and then this area was
covered with the membrane. A microperforation was done with a 1-mm diameter drill to attach the
membrane with a vitallium microscrew, and the membrane completely touched the bone underneath.
In the right tibiae, standard Cr-Co-Mo membranes were implanted using the same protocol; in the left
tibiae, high membranes were implanted. In the control rabbit, the same surgical procedure was done,
but a non-critical bone defect was made with a 3-mm diameter trephine, and no membrane was placed.
The surgical wound was sutured closed with Nylon 3.0 (Ethilon, Dilbeek, Belgium), and antibiotics
were administered. The sutures were removed after two weeks.
Biopsies were obtained from all of the extremities with a 3-mm diameter trephine close to
the membrane implantation site to analyse the cellular components of the bone surface before
membrane placement.
The animals were sacrificed at 20, 30, 40, and 60 days postoperatively, with an overdose of sodium
pentobarbital (Dolethals; Vetoquinol, Lure, Saint Anne, Alderney, France).
4.3. Analysis
A computerized axial tomography analysis (TAC, Multidetector CT Scanner Philips Brilliance®
of 64 channels) was performed. The augmented bone volumes were calculated from those images.
In addition, the mean density per unit area of the new bone was calculated.
For the densitometry analysis, a dental radiology apparatus (Carestream Health, Inc., 150,
Verona Street, Rochester, New York, NY, USA) was used to obtain density values of the new bone.
This information was then processed by an image analyser (ImageJ, NIH, Bethesda, ML, USA).
The distribution of density was calculated by comparing the grey levels of each image. The selected
areas were the augmented bone, used as a region of interest (ROIint, Figure 7a), and the cortical
bone before the membrane implantation, used as region of reference (ROIref, Figure 7b), with a size
selection window of 0.07 mm × 0.12 mm. Three measurements at different sites within the augmented
volume were taken and were presented as average ± standard deviation. Densitometric studies were
performed before the surgery and after the sacrifice of each animal.
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